NCT04560595View on ClinicalTrials.gov

Remote Guided Caffeine Reduction

NACompletedINTERVENTIONAL
Enrollment

109

Participants

Timeline

Start Date

September 10, 2020

Primary Completion Date

August 1, 2023

Study Completion Date

October 1, 2023

Conditions
Caffeine DependenceAnxietySleep DisturbanceGastrointestinal DysfunctionSleep Initiation and Maintenance DisordersCaffeine; Sleep DisorderCaffeineCaffeine-Induced Anxiety DisorderCaffeine WithdrawalCaffeine-Induced Sleep Disorder, Without Use DisorderCaffeine AbuseInsomniaAnxiety DisordersSleep DisorderHeartburnDiarrhea
Interventions
BEHAVIORAL

Caffeine Reduction Manual

We will provide participants with a Guide to Caffeine Reduction and Cessation in order to help the reduce their caffeine use and determine their ratings of treatment acceptability.

Trial Locations (1)

21224

Behavioral Pharmacology Research Unit, Johns Hopkins Bayview Medical Center, Baltimore

All Listed Sponsors
collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

Johns Hopkins University

OTHER

NCT04560595 - Remote Guided Caffeine Reduction | Biotech Hunter | Biotech Hunter